GleamWall
中文EN

FUNI Hypha Labs, Inc.

Services-Testing Laboratories · OTC · SEC CIK 1502966 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY36.7%
TTM EPS YoY66.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-729.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets4,618.5%
Debt / equity—
Current ratio0.01x
Interest coverage-4.40x

Cash quality & payout

Operating cash flow / net income0.30x
Accruals ratio-512.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-06-302026Q22026-03-312026Q12025-12-312025Q4*2025-09-302025Q32025-06-302025Q22025-03-312025Q12024-12-312024Q4*2024-09-30
Income statement
Revenue————————
SG&A expense$66,419$114,389$185,876$244,434$81,683$95,467$1.06M$260,235
Operating income-$95,953-$420,393-$475,020-$490,955-$536,027-$669,162-$1.31M-$568,843
Interest expense$154,509$100,721$46,618$35,113$25,996$22,660$22,374$21,867
Pretax income-$304,757-$521,114-$521,638-$558,415-$562,023-$641,822-$1.34M-$477,776
Income tax———————-$11,777
Net income-$304,757-$521,114-$521,638-$558,415-$562,023-$641,822-$1.34M-$465,999
EBITDA-$92,235-$416,674-$472,997-$487,720-$531,691-$667,327-$1.30M-$567,943
EPS (basic)0.000.000.00—0.000.00-0.01—
EPS (diluted)0.000.000.00—0.000.00-0.01—
Weighted avg. shares (diluted)163.90M159.45M151.71M—136.95M131.08M124.62M—
Balance sheet
Cash & equivalents$5,110$82,200$42,854$38,118$147,192$21,093$36,583$91,166
Current assets$15,280$96,375$314,590$320,531$340,380$186,963$177,703$410,190
PP&E, net$53,047$56,766$60,484$62,507$78,083$25,092$26,928$26,609
Total assets$68,327$159,819$391,601$409,218$454,103$256,969$258,643$493,805
Current liabilities$1.59M$1.43M$1.32M$1.12M$2.19M$1.73M$1.47M$1.39M
Long-term debt$1.81M$1.84M——————
Total debt$1.81M$1.84M——————
Total liabilities$3.16M$2.94M$2.74M$2.51M$2.19M$1.74M$1.49M$1.42M
Shareholders' equity-$3.42M-$3.12M-$2.69M-$2.44M-$2.07M-$1.82M-$1.56M-$1.26M
Net debt$1.80M$1.76M——————
Shares outstanding163.90M163.90M155.52M147.12M145.12M136.62M126.55M123.05M
Cash flow statement
Operating cash flow-$52,090-$50,654-$150,248-$315,063-$23,301-$33,659-$7,952-$435,846
Capital expenditure———$31,236$0-$1$1,731$10,188
Free cash flow———-$346,299-$23,301-$33,658-$9,683-$446,034
Investing cash flow———-$31,236$0$1-$1,731$47,984
Financing cash flow-$25,000$90,000$154,984$237,225$149,400$18,168-$44,900-$30,000
Depreciation & amortization$3,718$3,719$2,023$3,235$4,336$1,835$1,412$900
Stock-based compensation$0$0$218,131$112,682$313,059$389,063$1.04M$196,200

Free plan shows the latest 8 periods; Pro shows all 63 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.